The chlorinated insecticide chlordecone (Kepone) interacts with the estrogen receptor system. in the rat uterus in vitro and in vivo. It competes with estradiol for binding to the cytoplasmic receptor in vitro and also induces nuclear accumulation of estrogen receptor.sites in uteri in vitro. When injected into immature rats, chlordecone translocates estrogen receptor sites to the uterine nucleus, increases uterine weight, and stimulates the synthesis of the progesterone receptor, an estrogen receptor-mediated process. Its slow onset of action but prolonged duration of interaction with estrogen receptor and stimulation of uterine. weight gain and progesterone receptor synthesis indicates that, although it has an affinity for receptor only 0.01-0.04% that of estradiol, its considerable estrogenic activity may likely be derived from its long half-life and bioaccumulative character.
Reproductive disorders (namely, sterility as judged by oligospermia and hypomotile sperm) have been observed in male employees at a chlordecone (Kepone) manufacturing plant and have been associated with exposure to high levels of this chlorinated insecticide (1) . Previous examination of the toxicology of chlordecone in animals suggested that it might possess estrogenic properties: it induced constant estrus in mice (2) , suppressed spermatogenesis in male quail (3) , and caused hypertrophy of the oviduct in female quail (4) . Similar toxicological effects have been reported for another chlorinated insecticide, l-(o-chlorophenyl)-l-(p-chlorophenyl)-2,2,2-trichloroethane (o,p'-DDT), a contaminant in technical DDT (5, 6) . Hence, in these studies our aim was to determine whether chlordecone, a caged ring compound with a structure very different from that of both steroidal and nonsteroidal estrogens (see Fig. 1 ), was capable of interacting with the estrogen receptor system in a manner that might explain its estrogenic and growth-promoting activity. To study these interactions,, we have used the uterus of the immature rat, which is a well-studied model tissue for estrogen action (7, 8) . We have quantitated and characterized the interaction of chlordecone with the uterine estrogen receptor system in vitro and in vivo and have found that, although chlordecone has a low but clearly detectable affinity for the estrogen receptor, its persistent character results in long-term interaction with the estrogen receptor that produces a pronounced stimulation of uterine growth. Chlordecone is shown to be considerably more potent as an estrogen than is o,p'-DDT in this rat Fig. 1 ). Other radioinert compounds were estradiol-173 (Schwarz/Mann) and diethylstilbestrol (Sigma). Unlabeled.R5020 was kindly provided by J., P. Raynaud (Roussel-UCLAF, Romainville, France). The charcoal/dextran slurry contained 5% acid-washed Norit A (Sigma) and 0.5% dextran C (Schwarz/Mann) in 10 mM Tris-HCI/1.5 mM EDTA/0.02% sodium azide, pH 7.4 at 25°C.
Determination of Uterotrophic Activity. Groups of five rats each received subcutaneous injections of various amounts of compound or estradiol-17,B in 0.1 ml of sesame oil daily for 3 days and were killed 24 after. Whereas the rapid nuclear receptor accumulation after administration of estradiol was accompanied by a rapid depletion of cytoplasmic receptor sites, the more gradual nuclear accumulation of receptor after administration of chlordecone never resulted in marked cytoplasmic depletion. However, in both cases, cytoplasmic receptor levels began to rise after 3 hr, presumably due to receptor replenishment. The receptor distribution pattern seen with chlordecone was similar to that seen with weak, but long-acting, estrogens (18) .
As is characteristic of estrogens, chlordecone was also a potent stimulator of uterine progesterone receptor synthesis (Fig. 4) . At 20 mg/kg, chlordecone increased both weight and progesterone receptor content of the uterus. At 50 mg/kg, uterine weight was increased 4-fold and progesterone receptor production nearly 10-fold.
In an attempt to ascertain whether chlordecone might be exerting its estrogen-like action in vivo by direct interaction with estrogen receptors in the uterus, we studied its interaction with cytoplasmic and nuclear estrogen receptor in vitro. The relative binding affinity of chlordecone for the cytoplasmic estrogen receptor was determined by a competitive binding assay' (Fig. 5) . A comparison of the relative concentrations required to achieve 50% inhibition of the binding of [3H]estradiol 
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Medical Sciences: Hammond et al. 6 . Distribution of specific estrogen-binding sites between nuclear (A) and cytosol (B) fractions of the immature rat uterus after exposure of uteri to chlordecone or estrogen in vitro, as determined by nuclear and cytosol exchange assays. Uteri (three per group) were incubated in 3 ml of Eagle's HeLa medium with 0.1 jiM-1 mM chlordecone, 30 nM estradiol, or control vehicle (1% ethanol) for 2 hr at 371C. Each value represents the mean I SEM of three determinations in duplicate, with three separate groups (three uteri per group), and is corrected for nonspecific binding.
Chlordecone, at 0.1-1 mM, showed nuclear receptor movement and cytoplasmic receptor depletion of almost the same magnitude as that evoked by 30 nM estradiol (which is the lowest maximally effective, dose; ref. 19) . A comparison of the dose levels of chlordecone and estradiol for maximal receptor translocation or for half-maximal receptor translocation (for estradiol, 50% of maximal translocation is achieved with 2 nM; ref. 19) indicated that 10,000 times as much chlordecone as estradiol was required. This estimate of effectiveness of chlordecone (0.01% that of estradiol) is consistent with its affinity for the estrogen receptor in cell-free cytosol in vitro (Fig.  5) .
DISCUSSION
These studies indicate that chlordecone interacts with the estrogen receptor system in the uterus and, in vivo, behaves like a weak estrogen with prolonged activity. Hence, chlordecone competes with estradiol for binding to the cytoplasmic receptor, translocates receptor sites to the nucleus in vitro and in vivo, increases uterine weight, and stimulates synthesis of the progesterone receptor. The long-acting character of chlordecone is reflected in the slow but progressive increase in uterine weight that accompanies its action and by its ability to continue to increase uterine weight for time periods beyond that evoked by a single, high dose of estradiol (Fig. 3) . Its effects on receptor distribution profiles, in which nuclear,receptor levels increase gradually with -time and cytoplasmic receptor levels never appear markedly depleted, are also consistent with that seen with other weak estrogens having a prolonged biological halflife (18) .
The biological potency of chlordecone, as measured by uterotrophic activity in vivo, is consistent with its affinity for cytosol and nuclear estrogen receptor monitored in vitro. About 10,000 times as much chlordecone as estradiol is required to elicit an equal stimulation of uterine growth; chlordecone, likewise, has an affinity for cytoplasmic receptor that is 0.04% that of estradiol and an ability to translocate cytoplasmic receptor to the nuclear compartment of the uterus in vitro that is 0.01% that of estradiol. o,p'-DDT has an even lower affinity for the uterine estrogen receptor and did not increase uterine weight at dose levels that were maximally stimulatory with chlordecone. At higher dose levels, and in particular with the (-)-enantiomer, o,p'-DDT has been reported (5, 6, 20) to show estrogen-like uterotrophic activity in viro. o,p'-DDT bears some structural relationship to the potent estrogens diethylstilbestrol and hexestrol, so that its ability to compete with estradiol for binding to estrogen receptors in the uterus (5) might be expected. However, chlordecone is a caged ring compound with a structure very different from that of either the natural steroidal estrogens or the synthetic stilbestrol or hexestrol estrogens, and its significant affinity for estrogen receptor might not have been predicted.
The effects of chlordecone in the rat uterus appear to be explainable by its direct interaction with the estrogen receptor. Chlordecone action in the rat is not associated with any increase in the levels of estrogen in the blood (21) , and the finding that the level of cytoplasmic progesterone receptor is high in the uteri of animals exposed to chlordecone suggests minimal, if any, increases in the levels of circulating progesterone. In the chicken, however, chlordecone has been reported (22) to increase modestly the plasma level of progesterone and to act in the chicken oviduct in vivo as a combination of an estrogen and progestin, although it acts purely as an estrogen in vitro.
Although the affinity of chlordecone for estrogen receptors is admittedly weak, it may nevertheless be capable of inducing severe impairment of reproduction in chronically exposed individuals. Although the in vitro studies give strong evidence that chlordecone is itself estrogenic and can act directly on the uterus, more important is the observation of its prolonged interaction with estrogen receptors and protracted stimulation of uterine weight gain in vivo. Related findings of chlordecone interaction with the rat uterus have been reported recently (23) .
Chlordecone has a very long half-life in the body due to its unusual bioaccumulative properties (1, 24, 25) , and considerable amounts of this compound are sequestered in the liver and fat. We have found that after chronic exposure of mature female rats to 30 ppm of chlordecone in the feed for 7 weeks, all animals enter constant estrus and stop cycling. When killed at 10 weeks, the uteri of these animals were very enlarged and swollen with fluid. Hence, our data suggest that chronic exposure to this insecticide might impair reproductive function by acting, at least in part, as a low-affinity but very long-acting estrogen.
A point of particular interest is the marked quantitative differences in estrogenic potency and estrogen receptor affinity of chlordecone in different species. Chlordecone has a 100-fold higher affinity for estrogen receptor in the chicken oviduct (1% that of estradiol; ref. 22 ) than is seen here for estrogen receptor in the rat uterus, and only 50-to 100-fold higher concentrations of chlordecone than estradiol are needed for optimal induction of ovalbumin and conalbumin, two estrogen-stimulated proteins, in the chicken oviduct (22 (26) reported the affinity of chlordecone for chicken oviduct estrogen receptor to be 1/lOOOth-1/5000th that of estradiol, correcting a higher value that had been reported earlier (22) . The affinity and potency of chlordecone now reported in chicken oviduct is similar to that reported here for the rat uterus. We thank Richard Palmiter for bringing this report to our attention prior to its publication.
